>
产品中心 >
monoclonal_antibody >
NSJ Bio/CD80 Antibody / B7-1 [clone C80/1608] (V3297)/20 ug/V3297-20UG
![NSJ Bio/CD80 Antibody / B7-1 [clone C80/1608] (V3297)/20 ug/V3297-20UG](https://www.ebiomall.cn/images/NSJ/img-V3297-100UG-1.jpg)
T cell proliferation and lymphokine production are triggered by occupation of the TCR by antigen, followed by a costimulatory signal that is delivered by a ligand expressed on antigen presenting cells. The B7-related cell surface proteins CD80 (B7-1) and CD86 (B7-2) are expressed on antigen presenting cells bind the homologous T cell receptors CTLA-4 (cytotoxic T lymphocyte-associated protein-4) and CD28 and trigger costimulatory signals for optimal T cell activation. CTLA-4 shares 31% overall amino acid identity with CD28 and it has been proposed that CD28 and CTLA-4 are functionally redundant. SLAM is a novel receptor on T cells that, when engaged, potentiates T cell expansion in a CD28-independent manner. B7, also designated BB1, is another ligand or counter receptor for CD28 and CTLA-4 that is expressed on the antigen-presenting cell.
Optimal dilution of the CD80 antibody should be determined by the researcher.
Recombinant human protein used as the immunogen for the CD80 antibody.
Store the CD80 antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).